Hemizygous/homozygous and heterozygous JAK2 mutation detected in plasma of patients with myeloproliferative diseases: Correlation with clinical behaviour [3]

W. Ma*, H. Kantarjian, S. Verstovsek, I. Jilani, M. Gorre, F. Giles, J. Cortes, S. O'Brien, M. Keating, M. Albitar

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

14 Scopus citations
Original languageEnglish (US)
Pages (from-to)341-343
Number of pages3
JournalBritish Journal of Haematology
Volume134
Issue number3
DOIs
StatePublished - Aug 2006

Keywords

  • Essential thrombocythemia
  • Idiopathic myelofibrosis
  • JAK2
  • Mutations
  • Polycythemia vera

ASJC Scopus subject areas

  • Hematology

Cite this